Back to News
Market Impact: 0.6

Defense Stocks Just Got Even More Expensive

BAGDHIIKTOSLDOSLHXLMTNOCRTXTXTNDAQ
Infrastructure & DefenseCompany FundamentalsAnalyst InsightsInvestor Sentiment & PositioningMarket Technicals & FlowsGeopolitics & War
Defense Stocks Just Got Even More Expensive

Defense stocks are currently trading at significant premiums, with an average enterprise value-to-sales (EV/S) ratio of 2.77, nearly double their historical 20-year average 'fair value' of 1.40. Despite a recent rebound in prices and ongoing global geopolitical tensions, this elevated valuation suggests increased risk and limited upside for new investments. The analysis warns that, given current valuations, defense equities may underperform the broader market over the next decade.

Analysis

The U.S. defense sector is exhibiting signs of significant overvaluation, with a basket of ten major contractors currently trading at an average enterprise value-to-sales (EV/S) ratio of 2.77. This represents a substantial premium, nearly double the group's 20-year historical average of 1.40, which the analysis posits as a proxy for fair value. The valuation expansion has accelerated, rising from an average of 1.06 in the 2004-2013 period to 1.89 over the last decade. While ongoing geopolitical conflicts in Europe and the Middle East, alongside tensions in the South China Sea, provide a strong demand narrative, these catalysts appear to be fully priced in. The overvaluation is broad, with nine of the ten companies reviewed becoming more expensive recently. Kratos Defense & Security Solutions (KTOS) stands out with an exceptionally high EV/S of 9.20. Conversely, Lockheed Martin (LMT) has lagged following a significant profit miss, though its valuation remains above its historical average. This environment of stretched valuations suggests a heightened risk of future price corrections and potential for the sector to underperform the S&P 500 over the next decade.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo